PFE Operating Cash Flow Growth
Pfizer · Operating Cash Flow Growth
PFE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.76%period ending
PFE TTM Cash from Operations YoY % (-1.50% → -11.76%)
Year-over-year change
High-resolution chart · PNG
PFE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -11.7593% | |
| -14.3255% | |
| -8.1529% | |
| 16.1058% | |
| 89.7314% | |
| 63.099% | |
| 46.4828% | |
| -6.469% | |
| -45.0206% | |
| -64.1699% | |
| -70.2727% | |
| -54.7259% | |
| -53.7087% | |
| -30.781% | |
| -10.1719% | |
| -17.6303% | |
| 33.547% | |
| 118.769% | |
| 126.2029% | |
| 157.3603% | |
| 57.3595% | |
| 12.7291% | |
| 14.4185% | |
| -7.45% | |
| 4.6204% | |
| -9.7735% | |
| -20.465% | |
| -23.9695% | |
| -18.0595% | |
| -7.8392% | |
| -3.9041% | |
| 13.5732% | |
| 12.5516% | |
| 6.4714% | |
| 3.5784% | |
| 7.2258% | |
| 3.6413% | |
| 2.3323% | |
| 9.5714% | |
| -3.652% | |
| 2.2615% | |
| 5.7746% | |
| -14.0437% | |
| -12.0086% | |
| -21.7995% | |
| -20.727% | |
| -4.9648% | |
| 0.2089% | |
| 14.6111% | |
| 11.7305% | |
| 4.1691% | |
| 1.0317% | |
| -1.0003% | |
| -10.0751% | |
| -15.7411% | |
| -19.6732% | |
| -29.7517% | |
| -18.1867% | |
| 76.7068% | |
| 111.925% | |
| 215.6473% | |
| 217.1751% | |
| -30.9459% | |
| -43.4959% | |
| -57.6993% | |
| -60.9142% | |
| -9.0525% | |
| 10.6225% | |
| 4.9409% | |
| 17.7687% | |
| 36.5835% | |
| 14.0094% | |
| 25.0784% | |
| 3.3947% | |
| -24.1048% | |
| -21.2433% | |
| -20.5055% | |
| -4.1495% | |
| 19.419% | |
| 11.6915% | |
| -7.1354% | |
| -13.446% | |
| -9.8348% | |
| 8.4091% | |
| 45.8571% | |
| 63.2317% | |
| 39.1941% | |
| 33.1227% | |
| 18.2907% | |
| 0.3563% | |
| 15.2804% | |
| 24.1538% | |
| 14.4987% | |
| 21.3122% | |
| 9.932% | |
| -5.4873% | |
| 2.271% | |
| 29.9208% | |
| 49.5238% | |
| 95.7288% |